Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease : report of a phase I trial in bone marrow transplant recipientsAULITZKY, W. E; SCHULZ, T. F; DIERICH, M. P et al.The Journal of infectious diseases. 1991, Vol 163, Num 6, pp 1344-1347, issn 0022-1899, 4 p.Article

Low-dose ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromesGERHARTZ, H. H; VISANI, G; SIZOO, W et al.Bone marrow transplantation (Basingstoke). 1989, Vol 4, pp 36-37, issn 0268-3369, 2 p., suppl. 3Conference Paper

In vivo priming of human normal neutrophils by granulocyte-macrophage colony stimulating factor : effect on the production of platelet activating factorAGLIETTA, M; MONZEGLIO, C; APRA, F et al.British journal of haematology. 1990, Vol 75, Num 3, pp 333-339, issn 0007-1048, 7 p.Article

Granulocyte-macrophage colony-stimulating factor to hawest circulating haemopoietic stem cells for autotransplantationGIANNI, A. M; SIENA, S; BREGNI, M et al.Lancet (British edition). 1989, Num 8663, pp 580-585, issn 0140-6736Article

The side-effect profile of GM-CSFSTERN, A. C; JONES, T. C.Infection. Supplement. 1992, Vol 20, Num 2, pp S124-S127, issn 0173-2129Article

GM-CSF : intravenous versus subcutaneous treatmentAGLIETTA, M; MONZEGLIO, C; PIACIBELLO, W et al.Leukemia. 1990, Vol 4, Num 7, issn 0887-6924, p. 523Article

Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomasGERHARTZ, H. H; ENGELHARD, M; LENNERT, K et al.Seminars in oncology. 1994, Vol 21, Num 6, pp 25-28, issn 0093-7754, SUP16Conference Paper

Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapyGERHARTZ, H. H; STERN, A. C; WOLF-HORNUNG, B et al.Leukemia research. 1993, Vol 17, Num 2, pp 175-185, issn 0145-2126Article

Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction trealment of high-grade malignant non-Hodgkin's lymphomasGERHARTZ, H. H; ENGELHARD, M; GERHARTZ, D et al.Blood. 1993, Vol 82, Num 8, pp 2329-2339, issn 0006-4971Article

Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patientsSIENA, S; BREGNI, M; BRANDO, B et al.Blood. 1991, Vol 77, Num 2, pp 400-409, issn 0006-4971, 10 p.Article

Experimental and theoretical studies of the interaction of gas phase nitric acid and water with a self-assembled monolayerMOUSSA, S. G; STERN, A. C; RAFF, J. D et al.PCCP. Physical chemistry chemical physics (Print). 2013, Vol 15, Num 2, pp 448-458, issn 1463-9076, 11 p.Article

Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantationDE WITTE, T; GRATWOHL, A; VAN DER LELY, N et al.Blood. 1992, Vol 79, Num 5, pp 1359-1365, issn 0006-4971Article

Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulation factorHOLLANDER, A. A. M. J; KLUIN-NELEMANS, H. C; HAAK, H. R et al.Annals of hematology (Print). 1991, Vol 62, Num 1, pp 32-34, issn 0939-5555, 3 p.Article

In Vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cellsAGLIETTA, M; DE FELICE, L; MANDELLI, F et al.Leukemia. 1991, Vol 5, Num 11, pp 979-984, issn 0887-6924Article

Role of human recombinant GM-CSF in the prevention and treatment of leukopenia with special reference to infectious diseasesSTERN, A. C; JONES, T. C.Diagnostic microbiology and infectious disease. 1990, Vol 13, Num 5, pp 391-396, issn 0732-8893, 6 p.Conference Paper

Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugsAGLIETTA, M; MONZEGLIO, C; PASQUINO, P et al.Cancer. 1993, Vol 72, Num 10, pp 2970-2973, issn 0008-543XArticle

A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinomaDE VRIES, E. G. E; BIESMA, B; WILLEMSE, P. H. B et al.Cancer research (Baltimore). 1991, Vol 51, Num 1, pp 116-122, issn 0008-5472, 7 p.Article

Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapyDE VRIES, E. G. E; WILLEMSE, P. H. B; BIESMA, B et al.Lancet (British edition). 1991, Vol 338, Num 8765, pp 517-518, issn 0140-6736Article

In vivo effect of human granulocyte-macrophage colony-stimulating factor on megakaryocytopoiesisAGLIETTA, M; MONZEGLIO, C; STERN, A. C et al.Blood. 1991, Vol 77, Num 6, pp 1191-1194, issn 0006-4971Article

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and feverBIESMA, B; DE VRIES, E. G. E; WILLEMSE, P. H. B et al.European journal of cancer (1990). 1990, Vol 26, Num 9, pp 932-936, issn 0959-8049Article

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and relatively low risk of acute leukemiaWILLEMZE, R; VAN DER LELY, N; STRYCKMANS, P et al.Annals of hematology (Print). 1992, Vol 64, Num 4, pp 173-180, issn 0939-5555Article